266 related articles for article (PubMed ID: 34882298)
1. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
[TBL] [Abstract][Full Text] [Related]
2. Primary malignant melanoma of the esophagogastric junction: Report of a case.
Ishizaki M; Aibara Y; Furuya K
Int J Surg Case Rep; 2013; 4(8):700-3. PubMed ID: 23810918
[TBL] [Abstract][Full Text] [Related]
3. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report.
Ito S; Tachimori Y; Terado Y; Sakon R; Narita K; Goto M
J Med Case Rep; 2021 May; 15(1):237. PubMed ID: 33947459
[TBL] [Abstract][Full Text] [Related]
4. A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus.
Hanada K; Tsunoda S; Nomura M; Fujimura S; Yutaka Y; Nishigori T; Hisamori S; Maekewa H; Hoshino N; Itami A; Tanaka E; Obama K
Surg Case Rep; 2022 Nov; 8(1):206. PubMed ID: 36333558
[TBL] [Abstract][Full Text] [Related]
5. Primary malignant melanoma of the esophagogastric junction: A case report.
Chu YM; Hung CS; Huang CS
Medicine (Baltimore); 2021 Jun; 100(25):e26467. PubMed ID: 34160452
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Esophagogastric Junction Cancer Treated Successfully with Conversion Surgery after Complete Response to Nivolumab Treatment].
Yamazaki K; Taniguchi K; Yamane M; Hattori Y; Koizumi A; Shigehara F; Takashima J; Sugimoto H; Miura F; Matsutani N; Kobayashi H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2121-2123. PubMed ID: 35045512
[TBL] [Abstract][Full Text] [Related]
7. Primary Malignant Melanoma of the Esophagus Treated with Surgical Resection at an Early Stage.
Yoneda A; Ogata R; Ryu S; Yoshino K; Fukui S; Ikeda T; Kitasato A; Sugiyama N; Takeshita H; Minami S; Ito M; Kuroki T
Case Rep Gastroenterol; 2024; 18(1):189-194. PubMed ID: 38550658
[TBL] [Abstract][Full Text] [Related]
8. Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma-a case report.
Cerbon D; Moya-Brown K; Mihaylov IB; Spieler B
Front Oncol; 2023; 13():1143335. PubMed ID: 37182135
[TBL] [Abstract][Full Text] [Related]
9. Usage of nivolumab and ipilimumab for recurrent or advanced malignant vaginal melanoma: a two-case series.
Konishi K; Okamoto M; Tokumitsu R; Yano M; Nasu K; Kobayashi E
Med Mol Morphol; 2024 Jan; ():. PubMed ID: 38289480
[TBL] [Abstract][Full Text] [Related]
10. A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report.
Tanaka T; Arigami T; Uenosono Y; Yanagita S; Matsushita D; Okubo K; Kijima T; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Ishigami S; Natsugoe S
Surg Case Rep; 2020 Jan; 6(1):13. PubMed ID: 31919764
[TBL] [Abstract][Full Text] [Related]
11. Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis.
Takehara Y; Mimura K; Suzuki Y; Watanabe Y; Yoshimoto Y; Saze Z; Sato H; Tamaki T; Kono K
Cancer Rep (Hoboken); 2023 Jul; 6(7):e1832. PubMed ID: 37165926
[TBL] [Abstract][Full Text] [Related]
12. Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report.
Okamoto T; Nakano E; Yamauchi T
J Med Case Rep; 2021 Jul; 15(1):345. PubMed ID: 34256852
[TBL] [Abstract][Full Text] [Related]
13. Differential abscopal effect in extracranial and intracranial lesions after radiotherapy alone for vertebral bone metastasis of unknown primary: a case report.
Ishikawa Y; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Suzuki Y; Jingu K
J Med Case Rep; 2022 Mar; 16(1):94. PubMed ID: 35248152
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Esophagogastric Junction Adenocarcinoma with Multiple Esophageal Intramural Metastases].
Akamaru Y; Wada N; Wada R; Munakata K; Takiuchi D; Morimoto O; Ota H; Shibata K; Ohashi H
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2126-2128. PubMed ID: 30692306
[TBL] [Abstract][Full Text] [Related]
15. [Salvage Surgery for Unresectable Advanced Esophagogastric Junction Carcinoma with Multiple Liver Metastases after Successful Second-Line Treatment with Nab-Paclitaxel and Ramucirumab Following a Refractory Response to S-1 plus CDDP Therapy-A Case Report].
Fujita T; Shimizu Y; Dongping F; Yamamoto N; Kobayashi M; Iwabu H; Tsuji A
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1597-1600. PubMed ID: 33268735
[TBL] [Abstract][Full Text] [Related]
16. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
17. Primary Malignant Melanoma of the Gastroesophageal Junction Treated With Immunotherapy: A Case Report.
Attlassy N; Agbeh A; Patnaik R; Miller J; McCarthy J
WMJ; 2023 Mar; 122(1):77-80. PubMed ID: 36940130
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report.
Takagi K; Kamada T; Fuse Y; Kai W; Takahashi J; Nakashima K; Nakaseko Y; Suzuki N; Yoshida M; Okada S; Ohdaira H; Suzuki Y
Surg Case Rep; 2021 Oct; 7(1):221. PubMed ID: 34596772
[TBL] [Abstract][Full Text] [Related]
19. [A case of HER2-positive esophagogastric junction cancer treated by using a neoadjuvant chemotherapy regimen consisting of trastuzumab].
Kanaya N; Arata T; Tanakaya K; Yamasaki R; Aoki H; Takeuchi H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2285-6. PubMed ID: 25731497
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Primary Amelanotic Malignant Melanoma of the Esophagus, Wherein Pseudoprogression Was Suspected during Immune Checkpoint Inhibitor Treatment].
Matsumoto Y; Hirasawa S; Natsume T; Kainuma O; Tanaka H; Toyozumi T; Murakami K; Matsubara H; Maruyama T
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1251-1253. PubMed ID: 32829366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
